4942 J. Am. Chem. Soc., Vol. 119, No. 21, 1997
Blanc et al.
Procedure for Solid State Oligomerization. The synthesis was
performed using chloromethylated polystyrene-2% divinylbenzene
resin (Merck). The first unit was attached to the resin by mixing the
acid (3.4 mmol) in absolute ethanol (14 mL) with triethylamine (0.43
mL, 3 mmol) and polymeric resin (2.3 g) for 72 h at 80 °C. Subsequent
coupling steps on the polymeric support were carried out with freshly
prepared 1-hydroxybenzotriazole active esters of the monomer acids
in acetonitrile/methylene chloride (85/15 v/v) at room temperature
overnight. The active esters were prepared 2-3 h prior to each coupling
step by mixing monomer acid (2.0 mmol), 1-hydroxybenzotriazole (2.0
mmol), and N,N′-diisopropylcarbodiimide (2.2 mmol) in acetonitrile
at 0 °C.
CO), 1.19 (t, J ) 4.8 Hz, 3H, CH3). FT-IR (CDCl3, cm-1): ν 1728
(CdO ester), 1670 (CdO amide and hydroxamate).
Protected Ion Binding Chain 7. Hydrolysis of ester 6 according
to the general hydrolysis procedure provided the free acid. 1H NMR
(CDCl3): δ 7.60, 6.80 (ABq, J ) 8.7 Hz, 4H, anisoyl), 7.30-7.12,
(m, 10H, Ph), 6.65 (br t, 1H, NH), 4.76 (s, 2H, PhCH2O), 4.63 (s, 2H,
PhCH2O), 3.93 (m, 4H, CH2NO), 3.84 (s, 3H, OCH3), 3.49 (m, 2H,
CH2NH), 2.58-2.52 (m, 6H, CH2CO). FT-IR (CDCl3, cm-1): ν 1728
(CdO acid), 1670 (CdO amide and hydroxamate). Then, 2.0 g (3.6
mmol) of acid dissolved in 20 mL of acetonitrile was treated with 1.25
g (4.7 mmol) of pentachlorophenol, 450 mg of DMAP, and 0.8 mL
(5.1 mmol) of DICD overnight. The resulting mixture was concentrated
and chromatographed on silica gel (elution with hexane/chloroform,
chloroform, and chloroform/ethyl acetate mixtures) to provide 1.69 g
(1.95 mmol, 54% yield) of the active ester 7. 1H NMR (CDCl3): δ
7.68, 6.87 (ABq, J ) 8.7 Hz, 4H, anisoyl), 7.34, 7.28, 7.15 (m, 10H,
Ph), 6.50 (br t, 1H, NH), 4.82 (s, 2H, PhCH2O), 4.65 (s, 2H, PhCH2O),
4.01 (m, 4H, CH2NO), 3.84 (s, 3H, OCH3), 3.51 (m, 2H, CH2NH),
2.96 (t, J ) 6.9 Hz, 2H, CH2COOC6Cl5), 2.57 (m, 4H, CH2CO). FT-
IR (CDCl3, cm-1): ν 1780 (CdO active ester), 1663 (CdO amide and
hydroxamate).
(I) Ligand Synthesis. Intermittent Monomer 2. Condensation of
6.4 g (33.8 mmol) of N-Boc-â-alanine with 3-[N-(benzyloxy)amino]-
propionic acid ethyl ester75,76 (1) (8.29 g, 37.2 mmol) according to the
general coupling procedure provided 8.6 g (21.8 mmol, 64% yield) of
product 2. 1H NMR (CDCl3): δ 7.35 (m, 5H, Ph), 5.19 (br, 1H, NH),
4.78 (s, 2H, PhCH2O), 4.06 (q, J ) 7.1Hz, 2H, OCH2CH3), 3.95 (m,
2H, CH2NO), 3.36 (m, 2H, NCH2), 2.57 (m, 4H, CH2CO), 1.19 (t, J )
7.1 Hz, 3H, CH3). FT-IR (CDCl3, cm-1): ν 1715 (CdO ester), 1672
(CdO Boc and hydroxamate).
Ligand L1. A 225 mg (0.27 mmol) sample of active ester 7 was
dissolved in 10 mL of methylene chloride and stirred under argon with
0.010 mL (0.07 mmol) of tris(2-aminoethyl)amine (TREN, 8) and 20
mg of N-hydroxysuccinimide overnight. Then the mixture was
concentrated and chromatographed on silica gel with chloroform/
methanol as eluent to provide 84 mg (0.045 mmol, 64.2% yield) of
benzyl-protected ligand L1 (R ) Bn). 1H NMR (CDCl3): δ 7.7, 6.90
(ABq, J ) 8.7 Hz, 12H, anisoyl), 7.40-7.15 (m, 30H, Ph), 4.80 (m,
6H, PhCH2O), 4.75 (s, 6H, PhCH2O), 4.10 (m, 6H, CH2NO), 3.97 (m,
6H, CH2NO), 3.80 (s, 9H, OCH3), 3.50 (m, 6H, CH2CH2NH), 3.10
(m, 6H, CH2CH2NH), 2.6 (m, 6H, NCH2CH2NH), 2.50-2.45 (m, 12H,
CH2CO), 2.45 (m, 6H, CH2CO). FT-IR (CDCl3, cm-1): ν 1653 (CdO
amide and hydroxamate). A 200 mg (0.01 mmol) sample of protected
ligand L1 (R ) Bn) was dissolved in 50 mL of ethanol and
hydrogenated under atmospheric pressure in the presence of 75 mg of
Pd/C (10%) for 6 h. Filtration and concentration of the filtrate provided
104 mg of L1 (0.008 mmol, 80% yield). Mp: 140-145 °C. 1H NMR
(CDCl3/CD3OD): δ 7.7, 6.90 (ABq, J ) 8.7 Hz, 12H, anisoyl), 3.96
(m, 6H, CH2NO), 3.86 (m, 6H, CH2NO), 3.80 (s, 9H, OCH3), 3.43 (m,
6H, CH2CH2NH), 3.29 (m, 6H, CH2CH2NH), 2.6 (m, 6H, NCH2CH2-
NH), 2.57-2.51 (m, 18H, CH2CO). The assignment of the ligand’s
1H-NMR signals was confirmed by correlation spectroscopy (COSY),
which showed cross-peaks for each of the compound’s ethylene bridges
and for the two aromatic signals. FT-IR (KBr, cm-1): ν 1644 (CdO
amide and hydroxamate).
Ligand L2. Protected ligand L2 (R ) Bn) was prepared by
condensation of active ester 7 with trisamine 965 as described for the
preparation of protected ligand L1. 1H NMR (CD3OD, 10 mM): δ
7.56, 6.88 (ABq, J ) 8.7 Hz, 12H, anisoyl), 7.35-7.13 (m, 30H, Ph),
4.76 (m, 6H, PhCH2O), 4.66 (m, 6H, PhCH2O), 4.39 (m, 3H, CH-i-
Bu), 4.03 (m, 6H, CH2NO), 3.91 (m, 3H, CH2NO), 3.79 (s + m, 12H,
OCH3 + CH2NO), 3.37 (m, 12H, CH2CH2NH), 2.55 (m, 24H, CH2CO
and NCH2CH2NH), 1.60 (br, 9H, CH2{i-Bu} + CH{i-Bu}), 0.87-0.82
(m, 18H, CH3{i-Bu}). FT-IR (CDCl3 1.6 mM, cm-1): ν 3300 (NH),
1656, 1650, 1644 (CdO amide and hydroxamate). Hydrogenation of
protected ligand L2 (R ) Bn) as described for protected ligand L1
provided the free ligand L2. Mp: 105-110 °C. 1H NMR (CD3OD, 8
mM): δ 7.66, 6.93 (ABq, J ) 8.7 Hz, 12H, anisoyl), 4.36 (m, 3H,
CH-i-Bu), 3.97 (m, 6H, CH2NO), 3.86 (m, 6H, CH2NO), 3.82 (s, 9H,
OCH3), 3.65 (m, 3H, CH2CH2NH), 3.45 (m, 9H, CH2CH2NH), 2.67
(m, 6H, NCH2CH2NH), 2.60 (m, 18H, CH2CO), 1.65 (m, 9H, CH2{i-
Bu} + CH{i-Bu}), 0.93-0.88 (m, 18H, CH3{i-Bu}). FT-IR (KBr,
cm-1): ν 3284 (NH), 1657, 1650, 1643 (CdO amide and hydroxamate).
N-Boc-L-Aspartic Acid r-Diethyl Amide â-Benzyl Ester. Con-
densation of N-Boc-L-aspartic acid â-benzyl ester and diethylamine
according to the general coupling procedure, followed by column
chromatography using hexane/ethylacetate (1/1) as eluent, provided the
product in 41% yield. 1H NMR (CDCl3): δ 7.34 (s, 5H, Ph), 5.33 (d,
J ) 9.4 Hz, 1H, NH), 5.11 (m, 2H, CH2Ph), 4.95 (m, 1H, CH), 3.44
(m, 2H, NCH2CH3(trans)), 3.29 (m, 2H, NCH2CH3(cis)), 2.85 (dd, Jgem
) 15.8 Hz, Jvic ) 7.0 Hz, 1H, CHCH2), 2.65 (dd, Jgem ) 15.7 Hz, Jvic
Terminal Monomer 3. 3-[N-(Benzyloxy)amino]propionic acid ethyl
ester75,76 (1) (6.84 g, 30.6 mmol) was dissolved in 300 mL of dry toluene
and treated under ice, cooling first with 3.8 mL (30.4 mmol) of
triethylamine and then dropwise with 2.8 mL (26 mmol) of anisoyl
chloride dissolved in 50 mL of toluene. Then, the mixture was stirred
under cooling for 1 h and at room temperature for 1 h. The reaction
mixture was then washed with 1 M aqueous HCl, water, 1 M NaHCO3,
and water and dried over MgSO4. Concentration of the organic phase
and chromatography using hexane/ethyl acetate (7/3 v/v) as eluent
provided 7.45 g (22 mmol, 74.4% yield) of the ethyl ester of monomer
3. 1H NMR (CDCl3): δ 7.68, 6.85 (ABq, J ) 8.7 Hz, 4H, anisoyl),
7.30-7.26 (m, 5H, Ph), 4.66 (s, 2H, PhCH2O), 4.06 (q + t, 4H, OCH2-
CH3 and CH2NO), 3.84 (s, 3H, OCH3), 2.69 (t, J ) 6.6 Hz, 2H, CH2-
CO), 1.20 (t, J ) 6.6 Hz, 3H, CH3). FT-IR (CDCl3, cm-1): ν 1729
(CdO ester), 1631 (CdO hydroxamate). Hydrolysis of the ester
according to the general procedure afforded the monomer acid 3 in
49% yield. 1H NMR (CDCl3): δ 7.7, 6.88 (ABq, J ) 8.7 Hz, 4H,
anisoyl), 7.29-7.15 (m, 5H, Ph), 4.67 (s, 2H, PhCH2O), 4.06 (t, J )
6.8 Hz, 2H, CH2NO), 3.85 (s, 3H, OCH3), 2.74 (t, J ) 6.8 Hz, 2H,
CH2CO). FT-IR (CDCl3, cm-1): ν 1714 (CdO acid), 1629 (CdO
hydroxamate).
Protected Ion Binding Chain 6. Terminal monomer acid 3 was
activated by treating 2.2 g (7.35 mmol) of acid in 50 mL of acetonitrile
with 1.95 g (7.3 mmol) of pentachlorophenol, 150 mg of DMAP, and
1.2 mL (7.6 mmol) of DICD under cooling. After being stirred for
two days, the crude mixture was concentrated and chromatographed
first on neutral alumina (activity V) using chloroform as eluent and
then on silica gel (chloroform/hexane, 9/1 v/v) to provide 2.68 g (4.9
mmol, 64.9% yield) of activated ester 5. Mp: 103-106 °C. 1H NMR
(CDCl3): δ 7.75, 6.92 (ABq, J ) 8.7 Hz, 4H, anisoyl), 7.30-7.20 (m,
5H, Ph), 4.70 (s, 2H, PhCH2O), 4.19 (t, J ) 6.9 Hz, 2H, CH2NO),
3.87 (s, 3H, OCH3), 3.12 (t, J ) 6.9 Hz, 2H, CH2CO). FT-IR (CDCl3,
cm-1): ν 1780 (CdO active ester), 1633 (CdO hydroxamate).
Intermittent monomer 2 was deprotected by treating 2.5 g (6.34 mmol)
of compound with 4 mL of TFA in 8 mL of methylene chloride for 30
min at room temperature to provide 4. A 2.0 g sample of the
corresponding ammonium salt was dissolved in 1 mL of DMF,
neutralized with triethylamine, and then treated with 3.2 g (5.8 mmol)
of activated monomer 5 dissolved in 20 mL of methylene chloride in
the presence of 100 mg of imidazole. The reaction mixture was stirred
overnight at room temperature, concentrated, and chromatographed on
silica gel using chloroform as eluent to provide the ethyl ester 6. 1H
NMR (CDCl3): δ 7.75, 6.86 (ABq, J ) 8.7 Hz, 4H, anisoyl), 7.36-
7.27 (m, 10H, Ph), 6.5 (br t, 1H, NH), 4.74 (s, 2H, PhCH2O), 4.67 (s,
2H, PhCH2O), 4.07 (m, 4H, CH2NO and OCH2), 3.95 (m, 2H, CH2-
NO), 3.84 (s, 3H, OCH3), 3.45 (m, 2H, CH2NH), 2.55 (m, 6H, CH2-
(75) Yakirevitch, P.; Rochel, N.; Albrecht-Gary, A. M.; Libman, J.;
Shanzer, A. Inorg. Chem. 1993, 32, 1779-1787.
(76) Yakirevitch, P. Ph.D. Thesis, The Feinberg Graduate School of the
Weizmann Institute of Science, Rehovot, Israe¨l, 1992.